Health Care · S&P 500
Dexcom
A medical device company developing continuous glucose monitors and leading the market for real-time blood glucose monitoring for diabetics. S&P 500 constituent. Sector: Health Care (Health Care Equipment). Baseline node ahead of value-chain research; promoted to a full node once AI question demand is observed.
DXCM Updated Jul 11, 2026 2 AI consumers· 1 recurring
Annual return · 2026-07-10'21+45.2%'22-15.6%'23+9.6%'24-37.3%'25-14.7%YTD+12.9%
Money in ▸·
Dexcom~$4.0B
▸ Money out·
Financials & Segments
- Total revenue · ~$4.0B (FY2024)
- Segments · Sensors & Consumables · Hardware
Revenue from
No refined links yet.
Pays to
No refined links yet.